New hope for Tough-to-Treat nasopharyngeal cancer: targeted drug trial launches
NCT ID NCT06839066
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 21 times
Summary
This study tests a new drug called HLX43 in 70 people with advanced nasopharyngeal cancer that has come back or spread and did not respond to or could not tolerate standard second-line treatments. The drug is designed to target and attack cancer cells while sparing healthy ones. The goal is to see if it can shrink tumors and improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA (NPC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen
RECRUITINGShenzhen, Guangdong, China
-
Dongguan People's Hospital
RECRUITINGDongguan, Guangdong, China
-
First Affiliated Hospital of Gannan Medical University
RECRUITINGGanzhou, Jiangxi, China
-
Fujian Cancer Hospital
RECRUITINGFuzhou, Fujian, China
-
Guangxi Medical University Cancer Hospital
RECRUITINGNanning, Guangxi, China
-
Guizhou Medical University Cancer Hospital
RECRUITINGGuiyang, Guizhou, China
-
Sichuan Cancer Hospital
RECRUITINGChengdu, Sichuan, China
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, China
-
The First Affiliated Hospital of Guangdong Pharmaceutical University
RECRUITINGGuangzhou, Guangdong, China
-
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science & Technology
RECRUITINGWuhan, Hubei, China
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, China
-
West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, China
-
Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, China
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, Zhejiang, China
-
Zhongshan City People's Hospital
RECRUITINGGuangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.